Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia | Leukemia
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
What Is the Measure of Minimal Residual Disease in AML - The ASCO Post
The present and future of measurable residual disease testing in acute myeloid leukemia | Haematologica
MRD in AML: Prognosis, treatment, and surrogate endpoints
Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
MRD evaluation during treatment of AML patients according to ELN... | Download Scientific Diagram
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
MRD Tailored Therapy in AML: What We Have Learned So Far. - Abstract - Europe PMC
Measurable residual disease measurement methods in acute myeloid leukaemia. | Download Scientific Diagram
Role of MRD in elderly acute myeloid leukemia | CIA
Clinical implications of measurable residual disease in AML: Review of current evidence - ScienceDirect
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) | Leukemia
What is Measurable Residual Disease (MRD) | CatALLyst™
Frontiers | MRD Tailored Therapy in AML: What We Have Learned So Far
What Is Minimal Residual Disease (MRD) in Leukemia? | MyLeukemiaTeam
Minimal Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia | IntechOpen
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia | Leukemia
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML - ScienceDirect
a Minimal residual disease (MRD) in acute myeloid leukemia (AML) using... | Download Scientific Diagram
Biomedicines | Free Full-Text | Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions
MRD assessment in different therapeutic stadia of AML. | Download Scientific Diagram
Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) | FNIH
Role of MRD in elderly acute myeloid leukemia | CIA
